Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation

Recruiting now · Not applicable

Conditions studied: Fecal Microbiota Transplantation, Cesarean Section, Overweight and Obesity

In brief

This single-center randomized controlled trial evaluates whether donor-derived fecal microbiota transplantation (FMT) administered within 6 hours after birth can improve gut microbiota development and reduce the risk of immune-mediated and metabolic diseases in infants born by elective cesarean delivery. Newborns are randomized 1:1 to receive either donor-derived FMT or standard postnatal care. Participants are followed through 36 months of age with stool samples, questionnaires, growth assessments, and health data collection, with registry-based follow-up continuing until 10 years of age.

Key facts

Study ID
NCT06282952
Run by
Oulu University Hospital
People needed
460
Starts
2026-03-31
Expected to finish
2036-12-31
Last updated by the study team
2026-07-21

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.